Opportune Safety and Efficacy Information for Therapies Intended for COVID-19: Balancing Evidence and Expectations in an Emergency Context

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2020, Vol 4, Issue 2

Abstract

The SARS-CoV-2 outbreak has not only caused hundreds of thousands of deaths worldwide. It has also produced an accelerate and a notable increase in information about treatments that, in most cases, become rapidly outdated. The urgent need for effective therapies for COVID-19 prompted some regulatory bodies to allow the compassionate use of medicines authorized or in development for other indications with no sound-based evidence. The findings reported in some papers are widely discussed in mass media, despite their very preliminary nature and low methodological quality, and some politic leaders have announced some drugs as effective.

Authors and Affiliations

Herrera Comoglio R*

Keywords

Related Articles

Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases

CB2 receptor (CB2R) is one of the canonical cannabinoid receptor belonging to endocannabinoid system (ECS). It was cloned for the first time in 1993 from the human leukemia cell line HL-60, and it is part of the G-protei...

Examining the Practices and Challenges of Information Technology in Health Supply Chain Management in Alsabah Children’s Hospital, Juba, South Sudan

Background: This study was conducted to understand the practices and the challenges associated with information and communication technology in health supply chain management in Al Sabah children’s hospital in Juba, Sou...

Determination and Validation of RP-HPLC Method for the Estimation of Fosamprenavir in Tablet Dosage Form

A new simple, accurate, profitable, rapid-fire and precise rear phase high performance liquid chromatographic system has been developed for the validated of Fosamprenavir in bulk form and its pharmaceutical lozenge form...

Anthelmintic Activity of Methanolic Extract of Strychnos Colubrina L. Bark

Strychnoscolubrina L. (Loganiaceae) is being used in traditional medicine for a variety of ailments. One successive standard and three crude extract of its barks were subjected for anthelmintic activity on adult Indian e...

Ending the Ebola Virus Scourge A Case for Natural Products

We investigated the binding affinities of antiviral of ethno medicinal origin to five Ebola viral proteins by in silico molecular docking simulations. One hundred and seventy three compounds were obtained from literature...

Download PDF file
  • EP ID EP748459
  • DOI 10.23880/oajpr-16000203
  • Views 35
  • Downloads 0

How To Cite

Herrera Comoglio R* (2020). Opportune Safety and Efficacy Information for Therapies Intended for COVID-19: Balancing Evidence and Expectations in an Emergency Context. Open Access Journal of Pharmaceutical Research, 4(2), -. https://europub.co.uk./articles/-A-748459